A poor diagnosis
Giving developing countries better access to expensive, life-saving drugs has become a rallying cry among the rich. But treatment is hard unless you know what you are treating
EVERY day, thousands of people in poor countries are condemned to death without due process or a thorough investigation of their cases. If this were a miscarriage of justice, then human-rights activists would be up in arms. But it is a miscarriage of medicine instead, and until recently it has passed largely unnoticed by outsiders.
This article appeared in the Science & technology section of the print edition under the headline “A poor diagnosis”
From the September 2nd 2000 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Science & technology
Can you breathe stress away?
Scientists are only beginning to understand the links between the breath and the mind
The Economist’s science and technology internship
We invite applications for the 2025 Richard Casement internship
A better understanding of Huntington’s disease brings hope
Previous research seems to have misinterpreted what is going on
Is obesity a disease?
It wasn’t. But it is now
Volunteers with Down’s syndrome could help find Alzheimer’s drugs
Those with the syndrome have more of a protein implicated in dementia
Should you start lifting weights?
You’ll stay healthier for longer if you’re strong